[ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#assertion", "@graph": [ { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0040732", "http://wordnet-rdf.princeton.edu/lemma/compare": [ { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0439044" } ] } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#provenance", "@graph": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#assertion", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-12-16T19:34:32.283587", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasGeneratedBy": [ { "@value": "S&T TWOC project version 2" } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#version", "http://www.w3.org/ns/prov#value": [ { "@value": "2", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "with lenalidomide and dexamethasone alone ( Rd )" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "35", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "compared" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "[221]" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "lenalidomide and dexamethasone ( DRd ) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma" } ] }, { "@id": "http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "91", "@type": "http://www.w3.org/2001/XMLSchema#integer" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:6bnj8pcp&rows=50": [ { "@value": "6bnj8pcp" } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#SENTENCE", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide and dexamethasone alone (Rd)." } ] }, { "@id": "http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:6bnj8pcp-TRIPLE-ABSTRACT-5": [ { "@value": "6bnj8pcp-TRIPLE-ABSTRACT-5" } ] }, { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0040732", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "transplant" } ] }, { "@id": "https://uts.nlm.nih.gov/uts/umls/concept/C0439044", "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "alone" } ] } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#Head", "@graph": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#assertion", "http://www.w3.org/ns/prov#wasDerivedFrom": [ { "@id": "https://doi.org/10.1200/jco.20.01849" } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "fpN8XTakurncnZ/JwNCxxBXdawvEwrSe++9ajB8rVFAXnG0m7IFg3sprDsuEQfs33t7hZ3NrAD6TLVrgqjflGcSnVmMnYI4lmP6ANo22fI2FflZlPWaq3yHmQBfRkUncd4gRjNCtN0QSeTMBO8mFx/5LfdKvTuH8+AElukFa9bw=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk" } ] }, { "@id": "http://purl.org/np/RAIDToBjK8Vi59yHqPb7zOd3VgVmFUU3kWeHganAf_9Nk", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-12-16T19:34:32.283587", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-8954-0470" } ] } ] } ]